Aiming to illustrate an innovation model in an emerging market, this case summarizes the successful launch of drug-eluting stents at MicroPort and the development of innovation capabilities and culture within the company. The case also demonstrates a strategic dilemma appearing after one round of effective technological innovation and, more importantly, how understanding the value system — in this case, the health care system — is key to sustaining innovation.
|Number of pages||21|
|Publication status||Published - 1 Jan 2012|
GM-14-124GM-14-124-CEField2016-07-01China Europe International Business School
- Business model
- General Management